Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Stryker (SYK) Financials

Stryker logo
$391.48 +1.81 (+0.47%)
Closing price 03:59 PM Eastern
Extended Trading
$391.25 -0.23 (-0.06%)
As of 06:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Stryker

Annual Income Statements for Stryker

This table shows Stryker's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 515 1,439 1,647 1,020 3,553 2,083 1,599 1,994 2,358 3,165 2,993
Consolidated Net Income / (Loss)		 515 1,439 1,647 1,020 3,553 2,083 1,599 1,994 2,358 3,165 2,993
Net Income / (Loss) Continuing Operations		 515 1,439 1,647 1,020 3,553 2,083 1,599 1,994 2,358 3,165 2,993
Total Pre-Tax Income 		1,160 1,735 1,921 2,063 2,356 2,562 1,954 2,281 2,683 3,673 3,492
Total Operating Income		 1,246 1,861 2,175 2,297 2,537 2,713 2,223 2,584 2,841 3,888 3,689
Total Gross Profit		 6,356 6,602 7,504 8,180 8,938 9,696 9,057 10,968 11,578 13,058 14,440
Total Revenue		 9,675 9,946 11,325 12,444 13,601 14,884 14,351 17,108 18,449 20,498 22,595
Operating Revenue		 9,675 9,946 11,325 12,444 13,601 14,884 14,351 17,108 18,449 20,498 22,595
Total Cost of Revenue		 3,319 3,344 3,821 4,264 4,663 5,188 5,294 6,140 6,871 7,440 8,155
Operating Cost of Revenue		 3,319 3,344 3,821 4,264 4,663 5,188 5,294 6,140 6,871 7,440 8,155
Total Operating Expenses		 5,110 4,741 5,329 5,883 6,401 6,983 6,834 8,384 8,737 9,170 10,751
Selling, General & Admin Expense		 3,547 3,610 4,137 4,552 5,099 5,356 5,361 6,427 6,386 7,111 7,685
Research & Development Expense		 614 625 715 787 862 971 984 1,235 1,454 1,388 1,466
Amortization Expense		 188 210 319 371 417 464 472 619 627 635 623
Impairment Charge		 - - - - - - 0.00 0.00 270 36 977
Total Other Income / (Expense), net		 -86 -126 -254 -234 -181 -151 -269 -303 -158 -215 -197
Other Income / (Expense), net		 -86 -126 -254 -234 -181 -151 -269 -303 -158 -215 -197
Income Tax Expense		 645 296 274 1,043 -1,197 479 355 287 325 508 499
Basic Earnings per Share		 $1.36 $3.82 $4.40 $2.73 $9.50 $5.57 $4.26 $5.29 $6.23 $8.34 $7.86
Weighted Average Basic Shares Outstanding		 378.50M 376.60M 374.10M 374M 374.10M 374M 375.50M 377M 378.20M 379.60M 381M
Diluted Earnings per Share		 $1.34 $3.78 $4.35 $2.68 $9.34 $5.48 $4.20 $5.21 $6.17 $8.25 $7.76
Weighted Average Diluted Shares Outstanding		 382.80M 380.90M 378.50M 380.10M 380.30M 379.90M 380.30M 382.30M 382.20M 383.70M 385.60M
Weighted Average Basic & Diluted Shares Outstanding		 378.70M 376.70M 374.30M 373.60M 374M 374.58M 376.20M 377.54M 378.83M 380.26M 381.58M
Cash Dividends to Common per Share		 $1.26 $1.42 $1.57 $1.75 $1.93 $2.14 $2.36 $2.59 $2.84 $3.05 $3.24

Quarterly Income Statements for Stryker

This table shows Stryker's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 563 592 738 692 1,143 788 825 834 546 654 884
Consolidated Net Income / (Loss)		 563 592 738 692 1,143 788 825 834 546 654 884
Net Income / (Loss) Continuing Operations		 563 592 738 692 1,143 788 825 834 546 654 884
Total Pre-Tax Income 		761 679 899 869 1,226 923 998 1,043 528 764 1,016
Total Operating Income		 814 735 965 931 1,257 972 1,051 1,085 581 837 1,113
Total Gross Profit		 3,236 3,016 3,181 3,158 3,703 3,333 3,416 3,517 4,174 3,744 3,841
Total Revenue		 5,202 4,778 4,996 4,909 5,815 5,243 5,422 5,494 6,436 5,866 6,022
Operating Revenue		 5,202 4,778 4,996 4,909 5,815 5,243 5,422 5,494 6,436 5,866 6,022
Total Cost of Revenue		 1,966 1,762 1,815 1,751 2,112 1,910 2,006 1,977 2,262 2,122 2,181
Operating Cost of Revenue		 1,966 1,762 1,815 1,751 2,112 1,910 2,006 1,977 2,262 2,122 2,181
Total Operating Expenses		 2,422 2,281 2,216 2,227 2,446 2,361 2,365 2,432 3,593 2,907 2,728
Selling, General & Admin Expense		 1,682 1,781 1,709 1,710 1,911 1,837 1,831 1,896 2,102 2,300 2,079
Research & Development Expense		 326 339 346 353 350 368 363 377 358 405 407
Amortization Expense		 158 161 161 164 149 153 155 159 156 167 187
Impairment Charge		 - - - - - 3.00 16 - - 35 55
Total Other Income / (Expense), net		 -53 -56 -66 -62 -31 -49 -53 -42 -53 -73 -97
Other Income / (Expense), net		 -53 -56 -66 -62 -31 -49 -53 -42 -53 -73 -97
Income Tax Expense		 198 87 161 177 83 135 173 209 -18 110 132
Basic Earnings per Share		 $1.48 $1.56 $1.95 $1.82 $3.01 $2.07 $2.17 $2.18 $1.44 $1.71 $2.32
Weighted Average Basic Shares Outstanding		 378.20M 379M 379.70M 379.80M 379.60M 380.40M 381M 381.10M 381M 381.70M 382.20M
Diluted Earnings per Share		 $1.47 $1.54 $1.93 $1.80 $2.98 $2.05 $2.14 $2.16 $1.41 $1.69 $2.29
Weighted Average Diluted Shares Outstanding		 382.20M 383.20M 383.90M 384M 383.70M 385.10M 385.40M 385.60M 385.60M 386.40M 386.40M
Weighted Average Basic & Diluted Shares Outstanding		 378.83M 379.61M 379.78M 379.89M 380.26M 380.95M 381.08M 381.22M 381.58M 382.16M 382.31M
Cash Dividends to Common per Share		 - $0.75 $0.75 $0.75 - $0.80 $0.80 $0.80 - $0.84 $0.84

Annual Cash Flow Statements for Stryker

This table details how cash moves in and out of Stryker's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 456 1,584 -63 -774 1,082 721 -1,394 1.00 -1,100 1,127 681
Net Cash From Operating Activities		 1,782 981 1,915 1,559 2,610 2,191 3,277 3,263 2,624 3,711 4,242
Net Cash From Continuing Operating Activities		 1,782 981 1,915 1,559 2,610 2,191 3,277 3,263 2,624 3,711 4,242
Net Income / (Loss) Continuing Operations		 515 1,439 1,647 1,020 3,553 2,083 1,599 1,994 2,358 3,165 2,993
Consolidated Net Income / (Loss)		 515 1,439 1,647 1,020 3,553 2,083 1,599 1,994 2,358 3,165 2,993
Depreciation Expense		 190 187 227 271 306 314 340 371 371 393 427
Amortization Expense		 188 210 319 371 417 464 472 619 627 635 623
Non-Cash Adjustments To Reconcile Net Income		 925 -764 101 -218 82 225 405 583 450 241 1,252
Changes in Operating Assets and Liabilities, net		 -36 -91 -379 115 -1,748 -895 461 -304 -1,182 -723 -1,053
Net Cash From Investing Activities		 -1,878 1,956 -4,191 -1,613 -2,857 -1,455 -4,701 -859 -2,924 -962 -3,000
Net Cash From Continuing Investing Activities		 -1,878 1,956 -4,191 -1,613 -2,857 -1,455 -4,701 -859 -2,924 -962 -3,000
Purchase of Property, Plant & Equipment		 -233 -270 -490 -598 -572 -649 -487 -525 -588 -575 -755
Acquisitions		 -916 -153 -4,332 -831 -2,451 -802 -4,222 -339 -2,563 -390 -1,628
Purchase of Investments		 -4,365 -1,715 -151 -270 -226 -74 -54 -49 -52 -52 -808
Sale and/or Maturity of Investments		 3,636 4,094 785 87 394 69 61 55 240 54 148
Other Investing Activities, net		 0.00 0.00 -3.00 -1.00 -2.00 1.00 1.00 -1.00 39 1.00 43
Net Cash From Financing Activities		 629 -1,223 2,258 -794 1,329 3.00 -11 -2,365 -749 -1,594 -525
Net Cash From Continuing Financing Activities		 629 -1,223 2,258 -794 1,329 3.00 -11 -2,365 -749 -1,594 -525
Repayment of Debt		 -1,417 -2,266 -756 -233 -670 -1,349 -2,330 -1,306 -1,076 -1,541 -2,122
Payment of Dividends		 -462 -521 -568 -735 -717 -778 -863 -950 -1,051 -1,139 -1,219
Issuance of Debt		 2,587 2,320 3,662 499 3,136 2,573 3,292 5.00 1,500 1,241 3,011
Other Financing Activities, net		 21 -56 -67 -95 -120 -136 -110 -114 -122 -155 -195
Effect of Exchange Rate Changes		 -77 -130 -45 74 - -18 41 -38 -51 -28 -36
Cash Interest Paid		 102 101 180 231 248 286 304 325 324 356 396
Cash Income Taxes Paid		 437 497 510 312 539 457 323 622 505 693 989

Quarterly Cash Flow Statements for Stryker

This table details how cash moves in and out of Stryker's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents		 424 -173 -270 459 1,111 -641 -456 1,976 -198 -1,332 55
Net Cash From Operating Activities		 1,003 445 688 1,050 1,528 204 633 1,474 1,931 250 1,111
Net Cash From Continuing Operating Activities		 1,003 445 688 1,050 1,528 204 633 1,474 1,931 250 1,111
Net Income / (Loss) Continuing Operations		 563 592 738 692 1,143 788 825 834 546 654 884
Consolidated Net Income / (Loss)		 563 592 738 692 1,143 788 825 834 546 654 884
Depreciation Expense		 95 96 98 98 101 107 103 109 108 105 109
Amortization Expense		 158 161 161 164 149 153 155 159 156 167 187
Non-Cash Adjustments To Reconcile Net Income		 292 76 40 61 64 90 71 82 1,009 153 169
Changes in Operating Assets and Liabilities, net		 -105 -480 -349 35 71 -934 -521 290 112 -829 -238
Net Cash From Investing Activities		 -162 -132 -533 -145 -152 -408 -117 -2,172 -303 -4,136 -104
Net Cash From Continuing Investing Activities		 -162 -132 -533 -145 -152 -408 -117 -2,172 -303 -4,136 -104
Purchase of Property, Plant & Equipment		 -188 -130 -152 -148 -145 -167 -152 -170 -266 -123 -183
Acquisitions		 - 0.00 -390 - - -246 -88 -1,264 -30 -4,749 -65
Purchase of Investments		 -9.00 -28 -7.00 -6.00 -11 -18 -14 -759 -17 -11 -16
Sale and/or Maturity of Investments		 3.00 25 17 7.00 5.00 23 107 9.00 9.00 767 15
Other Investing Activities, net		 32 1.00 -1.00 2.00 -1.00 0.00 30 12 1.00 -20 -20
Net Cash From Financing Activities		 -446 -481 -405 -422 -286 -418 -966 2,653 -1,794 2,534 -989
Net Cash From Continuing Financing Activities		 -446 -481 -405 -422 -286 -418 -966 2,653 -1,794 2,534 -989
Repayment of Debt		 -150 -101 -101 -671 -668 -1.00 -648 -34 -1,440 -24 -654
Payment of Dividends		 -263 -284 -285 -285 -285 -304 -305 -305 -305 -320 -321
Other Financing Activities, net		 -33 -94 -17 -10 -34 -113 -14 -19 -49 -101 -14
Effect of Exchange Rate Changes		 29 - - - - -19 - - -32 20 37

Annual Balance Sheets for Stryker

This table presents Stryker's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 17,279 16,223 20,435 22,197 27,229 30,167 34,330 34,631 36,884 39,912 42,971
Total Current Assets		 8,684 7,943 7,861 7,993 9,733 11,058 9,707 10,017 10,275 12,518 14,847
Cash & Equivalents		 1,795 3,379 3,316 2,542 3,616 4,337 2,943 2,944 1,844 2,971 3,652
Short-Term Investments		 3,205 700 68 251 83 88 81 75 84 82 841
Accounts Receivable		 1,572 1,662 1,967 2,198 2,332 2,893 2,701 3,022 3,565 3,765 3,987
Inventories, net		 1,588 1,639 2,030 2,465 2,955 2,980 3,494 3,314 3,995 4,843 4,774
Prepaid Expenses		 524 563 480 537 747 760 488 662 787 857 1,593
Plant, Property, & Equipment, net		 1,098 1,199 1,569 1,975 2,291 2,567 2,752 2,833 2,970 3,215 3,448
Plant, Property & Equipment, gross		 2,597 2,730 3,161 3,800 4,277 4,714 5,182 5,498 5,805 6,344 6,683
Accumulated Depreciation		 1,499 1,531 1,592 1,825 1,986 2,147 2,430 2,665 2,835 3,129 3,235
Total Noncurrent Assets		 7,497 7,081 11,005 12,229 15,205 16,542 21,871 21,781 23,639 24,179 24,676
Goodwill		 4,186 4,136 6,356 7,168 8,563 9,069 12,778 12,918 14,880 15,243 15,855
Intangible Assets		 2,018 1,794 3,508 3,477 4,163 4,227 5,554 4,840 4,885 4,593 4,395
Noncurrent Deferred & Refundable Income Taxes		 - - - 283 1,678 1,575 1,530 1,760 1,410 1,670 1,742
Other Noncurrent Operating Assets		 1,293 1,151 1,141 1,301 801 1,671 2,009 2,263 2,464 2,673 2,684
Total Liabilities & Shareholders' Equity		 17,279 16,223 20,435 22,197 27,229 30,167 34,330 34,631 36,884 39,912 42,971
Total Liabilities		 8,684 7,712 10,885 12,217 15,499 17,360 21,246 19,754 20,268 21,319 22,337
Total Current Liabilities		 4,461 3,502 3,148 3,485 4,807 4,400 5,041 4,549 6,303 7,921 7,616
Short-Term Debt		 727 768 228 632 1,373 859 761 7.00 1,191 2,094 1,409
Accounts Payable		 329 410 437 487 646 675 810 1,129 1,413 1,517 1,679
Dividends Payable		 131 142 159 178 192 213 237 263 284 304 320
Current Deferred & Payable Income Tax Liabilities		 333 141 40 143 158 171 207 192 292 391 539
Current Employee Benefit Liabilities		 597 637 767 838 917 955 925 1,092 1,149 1,478 1,403
Other Current Liabilities		 751 710 923 1,207 1,521 1,196 1,586 1,465 1,744 2,137 2,266
Total Noncurrent Liabilities		 4,223 4,210 7,737 8,732 10,692 12,960 16,205 15,205 13,965 13,398 14,721
Long-Term Debt		 3,246 3,230 6,686 6,590 8,486 10,231 13,230 12,472 11,857 10,901 12,188
Noncurrent Deferred Revenue		 - - 287 1,261 1,228 1,068 990 913 641 567 349
Other Noncurrent Operating Liabilities		 977 980 764 881 978 1,661 1,985 1,820 1,467 1,930 2,184
Total Equity & Noncontrolling Interests		 8,595 8,511 9,550 9,980 11,730 12,807 13,084 14,877 16,616 18,593 20,634
Total Preferred & Common Equity		 8,595 8,511 9,550 9,966 11,730 12,807 13,084 14,877 16,616 18,593 20,634
Total Common Equity		 8,595 8,511 9,550 9,966 11,730 12,807 13,084 14,877 16,616 18,593 20,634
Common Stock		 1,290 1,358 1,469 1,533 1,596 1,665 1,779 1,928 2,072 2,238 2,399
Retained Earnings		 7,559 7,792 8,842 8,986 10,765 11,748 12,462 13,480 14,765 16,771 18,528
Accumulated Other Comprehensive Income / (Loss)		 -254 -639 -761 -553 -631 -606 -1,157 -531 -221 -416 -293

Quarterly Balance Sheets for Stryker

This table presents Stryker's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Total Assets		 36,884 36,830 37,409 38,042 39,912 39,402 39,130 43,833 42,971 46,006 46,331
Total Current Assets		 10,275 10,155 10,151 11,045 12,518 11,892 11,645 14,673 14,847 13,022 13,003
Cash & Equivalents		 1,844 1,671 1,401 1,860 2,971 2,330 1,874 3,850 3,652 2,320 2,375
Short-Term Investments		 84 86 77 76 82 77 83 834 841 89 89
Accounts Receivable		 3,565 3,215 3,261 3,276 3,765 3,473 3,622 3,736 3,987 3,961 3,918
Inventories, net		 3,995 4,333 4,593 4,883 4,843 5,026 5,044 5,292 4,774 5,105 5,289
Prepaid Expenses		 787 850 819 950 857 986 1,022 961 1,593 1,547 1,332
Plant, Property, & Equipment, net		 2,970 3,037 3,082 3,106 3,215 3,260 3,318 3,429 3,448 3,536 3,702
Plant, Property & Equipment, gross		 5,805 5,970 6,087 6,155 6,344 6,458 6,622 6,889 6,683 6,910 7,272
Accumulated Depreciation		 2,835 2,933 3,005 3,049 3,129 3,198 3,304 3,460 3,235 3,374 3,570
Total Noncurrent Assets		 23,639 23,638 24,176 23,891 24,179 24,250 24,167 25,731 24,676 29,448 29,626
Goodwill		 14,880 14,849 15,172 15,138 15,243 15,351 15,408 16,396 15,855 19,089 19,183
Intangible Assets		 4,885 4,779 4,917 4,731 4,593 4,509 4,363 4,940 4,395 6,132 5,962
Noncurrent Deferred & Refundable Income Taxes		 1,410 1,443 1,439 1,406 1,670 1,641 1,606 1,562 1,742 1,411 1,375
Other Noncurrent Operating Assets		 2,464 2,567 2,648 2,616 2,673 2,749 2,790 2,833 2,684 2,816 3,106
Total Liabilities & Shareholders' Equity		 36,884 36,830 37,409 38,042 39,912 39,402 39,130 43,833 42,971 46,006 46,331
Total Liabilities		 20,268 19,935 20,048 20,137 21,319 20,230 19,368 23,684 22,337 25,076 25,140
Total Current Liabilities		 6,303 5,866 6,584 7,458 7,921 6,955 6,926 7,669 7,616 7,929 7,288
Short-Term Debt		 1,191 1,204 1,798 2,308 2,094 2,058 2,095 2,159 1,409 2,398 1,751
Accounts Payable		 1,413 1,366 1,326 1,296 1,517 1,246 1,304 1,337 1,679 1,464 1,442
Dividends Payable		 284 285 284 285 304 305 305 305 320 320 321
Current Deferred & Payable Income Tax Liabilities		 292 371 298 407 391 444 334 394 539 599 91
Current Employee Benefit Liabilities		 1,149 713 929 1,223 1,478 778 887 1,250 1,403 919 1,075
Other Current Liabilities		 1,744 1,700 1,729 1,715 2,137 2,124 2,001 2,224 2,266 2,229 2,608
Total Noncurrent Liabilities		 13,965 14,069 13,464 12,679 13,398 13,275 12,442 16,015 14,721 17,147 17,852
Long-Term Debt		 11,857 11,857 11,149 10,382 10,901 10,807 10,127 13,325 12,188 14,383 14,829
Noncurrent Deferred Revenue		 641 625 469 465 567 565 350 368 349 372 395
Other Noncurrent Operating Liabilities		 1,467 1,587 1,846 1,832 1,930 1,903 1,965 2,322 2,184 2,392 2,628
Total Equity & Noncontrolling Interests		 16,616 16,895 17,361 17,905 18,593 19,172 19,762 20,149 20,634 20,930 21,191
Total Preferred & Common Equity		 16,616 16,895 17,361 17,905 18,593 19,172 19,762 20,149 20,634 20,930 21,191
Total Common Equity		 16,616 16,895 17,361 17,905 18,593 19,172 19,762 20,149 20,634 20,930 21,191
Common Stock		 2,072 2,128 2,165 2,221 2,238 2,295 2,343 2,391 2,399 2,477 2,530
Retained Earnings		 14,765 15,072 15,526 15,933 16,771 17,254 17,774 18,303 18,528 18,862 19,423
Accumulated Other Comprehensive Income / (Loss)		 -221 -305 -330 -249 -416 -377 -355 -545 -293 -409 -762

Annual Metrics And Ratios for Stryker

This table displays calculated financial ratios and metrics derived from Stryker's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 7.25% 2.80% 13.86% 9.88% 9.30% 9.43% -3.58% 19.21% 7.84% 11.11% 10.23%
EBITDA Growth		 1.25% 38.62% 15.71% 9.65% 13.83% 8.48% -17.19% 18.26% 12.53% 27.71% -3.38%
EBIT Growth		 -4.29% 49.57% 10.72% 7.39% 14.20% 8.74% -23.73% 16.73% 17.62% 36.90% -4.93%
NOPAT Growth		 -46.94% 179.02% 20.81% -39.10% 236.88% -42.35% -17.53% 24.17% 10.54% 34.18% -5.62%
Net Income Growth		 -48.81% 179.42% 14.45% -38.07% 248.33% -41.37% -23.24% 24.70% 18.25% 34.22% -5.43%
EPS Growth		 -49.05% 182.09% 15.08% -38.39% 248.51% -41.33% -23.36% 24.05% 18.43% 33.71% -5.94%
Operating Cash Flow Growth		 -5.51% -44.95% 95.21% -18.59% 67.42% -16.05% 49.57% -0.43% -19.58% 41.43% 14.31%
Free Cash Flow Firm Growth		 209.84% -16.21% -517.93% 92.42% 255.89% 82.13% -561.85% 169.93% -147.42% 374.20% -23.25%
Invested Capital Growth		 -3.11% 11.34% 54.44% 10.18% 23.96% 8.87% 23.38% 1.28% 13.90% 2.92% 4.23%
Revenue Q/Q Growth		 1.57% 0.98% 4.06% 2.59% 2.45% 2.30% 0.92% 2.63% 2.79% 3.08% 2.83%
EBITDA Q/Q Growth		 2.95% 8.28% 0.78% 3.01% 0.49% 9.80% -7.89% 3.19% 0.52% 10.90% -13.09%
EBIT Q/Q Growth		 2.65% 9.53% -1.23% 3.05% 0.34% 12.22% -11.94% 3.92% 0.15% 14.50% -16.66%
NOPAT Q/Q Growth		 -19.27% 23.57% 1.54% -43.27% 184.69% -40.42% -4.93% 3.80% -4.34% 20.69% -15.46%
Net Income Q/Q Growth		 -19.66% 22.26% -0.72% -42.66% 187.46% -39.20% -8.94% 4.95% -4.03% 22.44% -16.63%
EPS Q/Q Growth		 -20.24% 23.13% -0.91% -42.74% 188.27% -39.25% -8.89% 4.83% -4.04% 22.40% -16.83%
Operating Cash Flow Q/Q Growth		 0.39% 8.16% -4.73% 1.37% 16.36% -12.43% 18.09% -6.77% 0.11% 16.48% 10.50%
Free Cash Flow Firm Q/Q Growth		 192.43% 22.11% -2.29% -216.62% -76.94% 489.19% -270.63% 163.13% 2.81% 39.08% 35.87%
Invested Capital Q/Q Growth		 -4.05% -1.74% -0.46% -3.53% 20.31% 4.23% 26.71% 0.70% 0.11% -0.36% -3.83%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 65.70% 66.38% 66.26% 65.73% 65.72% 65.14% 63.11% 64.11% 62.76% 63.70% 63.91%
EBITDA Margin		 15.90% 21.44% 21.78% 21.74% 22.64% 22.44% 19.27% 19.12% 19.95% 22.93% 20.10%
Operating Margin		 12.88% 18.71% 19.21% 18.46% 18.65% 18.23% 15.49% 15.10% 15.40% 18.97% 16.33%
EBIT Margin		 11.99% 17.44% 16.96% 16.58% 17.32% 17.21% 13.62% 13.33% 14.54% 17.92% 15.45%
Profit (Net Income) Margin		 5.32% 14.47% 14.54% 8.20% 26.12% 13.99% 11.14% 11.66% 12.78% 15.44% 13.25%
Tax Burden Percent		 44.40% 82.94% 85.74% 49.44% 150.81% 81.30% 81.83% 87.42% 87.89% 86.17% 85.71%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 55.60% 17.06% 14.26% 50.56% -50.81% 18.70% 18.17% 12.58% 12.11% 13.83% 14.29%
Return on Invested Capital (ROIC)		 7.07% 18.97% 17.10% 8.16% 23.42% 11.68% 8.27% 9.24% 9.49% 11.78% 10.74%
ROIC Less NNEP Spread (ROIC-NNEP)		 10.90% 44.00% 5.48% 5.37% 18.44% 9.83% 5.84% 6.71% 8.18% 10.07% 9.02%
Return on Net Nonoperating Assets (RNNOA)		 -1.23% -2.15% 1.14% 2.28% 9.31% 5.30% 4.08% 5.02% 5.48% 6.19% 4.52%
Return on Equity (ROE)		 5.84% 16.82% 18.24% 10.45% 32.73% 16.98% 12.35% 14.26% 14.97% 17.98% 15.26%
Cash Return on Invested Capital (CROIC)		 10.23% 8.24% -25.70% -1.53% 2.03% 3.19% -12.66% 7.96% -3.51% 8.90% 6.60%
Operating Return on Assets (OROA)		 7.03% 10.36% 10.48% 9.68% 9.53% 8.93% 6.06% 6.62% 7.50% 9.57% 8.43%
Return on Assets (ROA)		 3.12% 8.59% 8.99% 4.79% 14.38% 7.26% 4.96% 5.78% 6.59% 8.24% 7.22%
Return on Common Equity (ROCE)		 5.84% 16.82% 18.24% 10.44% 32.71% 16.98% 12.35% 14.26% 14.97% 17.98% 15.26%
Return on Equity Simple (ROE_SIMPLE)		 5.99% 16.91% 17.25% 10.23% 30.29% 16.26% 12.22% 13.40% 14.19% 17.02% 14.51%
Net Operating Profit after Tax (NOPAT)		 553 1,544 1,865 1,136 3,826 2,206 1,819 2,259 2,497 3,350 3,162
NOPAT Margin		 5.72% 15.52% 16.47% 9.13% 28.13% 14.82% 12.68% 13.20% 13.53% 16.34% 13.99%
Net Nonoperating Expense Percent (NNEP)		 -3.82% -25.03% 11.61% 2.79% 4.98% 1.86% 2.43% 2.53% 1.31% 1.71% 1.72%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 8.42% 10.61% 9.24%
Cost of Revenue to Revenue		 34.30% 33.62% 33.74% 34.27% 34.28% 34.86% 36.89% 35.89% 37.24% 36.30% 36.09%
SG&A Expenses to Revenue		 36.66% 36.30% 36.53% 36.58% 37.49% 35.99% 37.36% 37.57% 34.61% 34.69% 34.01%
R&D to Revenue		 6.35% 6.28% 6.31% 6.32% 6.34% 6.52% 6.86% 7.22% 7.88% 6.77% 6.49%
Operating Expenses to Revenue		 52.82% 47.67% 47.06% 47.28% 47.06% 46.92% 47.62% 49.01% 47.36% 44.74% 47.58%
Earnings before Interest and Taxes (EBIT)		 1,160 1,735 1,921 2,063 2,356 2,562 1,954 2,281 2,683 3,673 3,492
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,538 2,132 2,467 2,705 3,079 3,340 2,766 3,271 3,681 4,701 4,542
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.71 3.72 4.32 5.41 4.71 5.84 6.78 6.59 5.46 6.06 6.65
Price to Tangible Book Value (P/TBV)		 13.33 12.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 357.44
Price to Revenue (P/Rev)		 3.29 3.18 3.64 4.33 4.06 5.02 6.18 5.73 4.92 5.50 6.07
Price to Earnings (P/E)		 61.87 21.98 25.03 52.85 15.54 35.89 55.45 49.20 38.47 35.62 45.86
Dividend Yield		 1.50% 1.68% 1.42% 1.21% 1.31% 1.07% 1.00% 0.99% 1.18% 1.03% 0.90%
Earnings Yield		 1.62% 4.55% 4.00% 1.89% 6.44% 2.79% 1.80% 2.03% 2.60% 2.81% 2.18%
Enterprise Value to Invested Capital (EV/IC)		 4.01 3.68 3.38 4.00 3.39 4.14 4.10 4.37 3.63 4.25 4.87
Enterprise Value to Revenue (EV/Rev)		 3.19 3.17 3.95 4.69 4.51 5.47 6.94 6.29 5.52 5.98 6.48
Enterprise Value to EBITDA (EV/EBITDA)		 20.05 14.80 18.14 21.57 19.93 24.38 36.02 32.89 27.66 26.09 32.22
Enterprise Value to EBIT (EV/EBIT)		 26.58 18.19 23.30 28.28 26.05 31.78 50.99 47.16 37.95 33.40 41.91
Enterprise Value to NOPAT (EV/NOPAT)		 55.74 20.44 24.00 51.38 16.04 36.91 54.77 47.62 40.78 36.61 46.29
Enterprise Value to Operating Cash Flow (EV/OCF)		 17.30 32.16 23.37 37.43 23.51 37.16 30.40 32.97 38.80 33.05 34.50
Enterprise Value to Free Cash Flow (EV/FCFF)		 38.54 47.06 0.00 0.00 185.43 135.07 0.00 55.25 0.00 48.46 75.33
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.46 0.47 0.72 0.72 0.84 0.87 1.07 0.84 0.79 0.70 0.66
Long-Term Debt to Equity		 0.38 0.38 0.70 0.66 0.72 0.80 1.01 0.84 0.71 0.59 0.59
Financial Leverage		 -0.11 -0.05 0.21 0.42 0.50 0.54 0.70 0.75 0.67 0.61 0.50
Leverage Ratio		 1.87 1.96 2.03 2.18 2.28 2.34 2.49 2.47 2.27 2.18 2.11
Compound Leverage Factor		 1.87 1.96 2.03 2.18 2.28 2.34 2.49 2.47 2.27 2.18 2.11
Debt to Total Capital		 31.61% 31.96% 41.99% 41.98% 45.67% 46.41% 51.68% 45.62% 43.99% 41.14% 39.72%
Short-Term Debt to Total Capital		 5.78% 6.14% 1.38% 3.67% 6.36% 3.59% 2.81% 0.03% 4.02% 6.63% 4.12%
Long-Term Debt to Total Capital		 25.83% 25.82% 40.61% 38.31% 39.31% 42.81% 48.86% 45.59% 39.97% 34.51% 35.61%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.08% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 68.39% 68.04% 58.01% 57.94% 54.33% 53.59% 48.33% 54.38% 56.01% 58.86% 60.28%
Debt to EBITDA		 2.58 1.88 2.80 2.67 3.20 3.32 5.06 3.82 3.54 2.76 2.99
Net Debt to EBITDA		 -0.67 -0.04 1.43 1.64 2.00 2.00 3.96 2.89 3.02 2.11 2.00
Long-Term Debt to EBITDA		 2.11 1.52 2.71 2.44 2.76 3.06 4.78 3.81 3.22 2.32 2.68
Debt to NOPAT		 7.18 2.59 3.71 6.36 2.58 5.03 7.69 5.52 5.23 3.88 4.30
Net Debt to NOPAT		 -1.86 -0.05 1.89 3.90 1.61 3.02 6.03 4.19 4.45 2.97 2.88
Long-Term Debt to NOPAT		 5.87 2.09 3.59 5.80 2.22 4.64 7.27 5.52 4.75 3.25 3.85
Altman Z-Score		 3.89 4.43 4.02 4.33 3.69 4.17 3.78 4.43 4.12 4.72 5.29
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.07% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.95 2.27 2.50 2.29 2.02 2.51 1.93 2.20 1.63 1.58 1.95
Quick Ratio		 1.47 1.64 1.70 1.43 1.25 1.66 1.14 1.33 0.87 0.86 1.11
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 800 671 -2,802 -212 331 603 -2,784 1,947 -923 2,531 1,943
Operating Cash Flow to CapEx		 764.81% 363.33% 390.82% 260.70% 456.29% 337.60% 672.90% 621.52% 446.26% 645.39% 561.85%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.59 0.59 0.62 0.58 0.55 0.52 0.45 0.50 0.52 0.53 0.55
Accounts Receivable Turnover		 6.26 6.15 6.24 5.98 6.00 5.70 5.13 5.98 5.60 5.59 5.83
Inventory Turnover		 2.21 2.07 2.08 1.90 1.72 1.75 1.64 1.80 1.88 1.68 1.70
Fixed Asset Turnover		 8.88 8.66 8.18 7.02 6.38 6.13 5.40 6.13 6.36 6.63 6.78
Accounts Payable Turnover		 10.32 9.05 9.02 9.23 8.23 7.85 7.13 6.33 5.41 5.08 5.10
Days Sales Outstanding (DSO)		 58.29 59.34 58.48 61.08 60.78 64.07 71.14 61.05 65.16 65.26 62.61
Days Inventory Outstanding (DIO)		 165.51 176.11 175.24 192.39 212.13 208.78 223.18 202.36 194.13 216.79 215.22
Days Payable Outstanding (DPO)		 35.36 40.33 40.45 39.55 44.34 46.47 51.19 57.63 67.52 71.87 71.52
Cash Conversion Cycle (CCC)		 188.44 195.12 193.27 213.92 228.57 226.37 243.12 205.77 191.78 210.18 206.31
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 7,699 8,572 13,239 14,587 18,082 19,685 24,288 24,600 28,020 28,839 30,058
Invested Capital Turnover		 1.24 1.22 1.04 0.89 0.83 0.79 0.65 0.70 0.70 0.72 0.77
Increase / (Decrease) in Invested Capital		 -247 873 4,667 1,348 3,495 1,603 4,603 312 3,420 819 1,219
Enterprise Value (EV)		 30,837 31,552 44,752 58,346 61,369 81,414 99,632 107,567 101,822 122,665 146,361
Market Capitalization		 31,864 31,633 41,222 53,903 55,209 74,749 88,665 98,107 90,702 112,723 137,257
Book Value per Share		 $22.72 $22.66 $25.50 $26.63 $31.35 $34.21 $34.82 $39.44 $43.91 $48.94 $54.13
Tangible Book Value per Share		 $6.32 $6.87 ($0.84) ($1.81) ($2.66) ($1.31) ($13.97) ($7.64) ($8.32) ($3.27) $1.01
Total Capital		 12,568 12,509 16,464 17,202 21,589 23,897 27,075 27,356 29,664 31,588 34,231
Total Debt		 3,973 3,998 6,914 7,222 9,859 11,090 13,991 12,479 13,048 12,995 13,597
Total Long-Term Debt		 3,246 3,230 6,686 6,590 8,486 10,231 13,230 12,472 11,857 10,901 12,188
Net Debt		 -1,027 -81 3,530 4,429 6,160 6,665 10,967 9,460 11,120 9,942 9,104
Capital Expenditures (CapEx)		 233 270 490 598 572 649 487 525 588 575 755
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -50 1,130 1,557 2,347 2,600 3,092 2,403 2,456 3,235 3,638 4,147
Debt-free Net Working Capital (DFNWC)		 4,950 5,209 4,941 5,140 6,299 7,517 5,427 5,475 5,163 6,691 8,640
Net Working Capital (NWC)		 4,223 4,441 4,713 4,508 4,926 6,658 4,666 5,468 3,972 4,597 7,231
Net Nonoperating Expense (NNE)		 38 105 218 116 273 123 220 265 139 185 169
Net Nonoperating Obligations (NNO)		 -896 61 3,689 4,607 6,352 6,878 11,204 9,723 11,404 10,246 9,424
Total Depreciation and Amortization (D&A)		 378 397 546 642 723 778 812 990 998 1,028 1,050
Debt-free, Cash-free Net Working Capital to Revenue		 -0.52% 11.36% 13.75% 18.86% 19.12% 20.77% 16.74% 14.36% 17.53% 17.75% 18.35%
Debt-free Net Working Capital to Revenue		 51.16% 52.37% 43.63% 41.31% 46.31% 50.50% 37.82% 32.00% 27.99% 32.64% 38.24%
Net Working Capital to Revenue		 43.65% 44.65% 41.62% 36.23% 36.22% 44.73% 32.51% 31.96% 21.53% 22.43% 32.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.36 $3.82 $4.40 $2.73 $9.50 $5.57 $4.26 $5.29 $6.23 $8.34 $7.86
Adjusted Weighted Average Basic Shares Outstanding		 378.50M 376.60M 374.10M 374M 374.10M 374M 375.50M 377M 378.20M 379.60M 381M
Adjusted Diluted Earnings per Share		 $1.34 $3.78 $4.35 $2.68 $9.34 $5.48 $4.20 $5.21 $6.17 $8.25 $7.76
Adjusted Weighted Average Diluted Shares Outstanding		 382.80M 380.90M 378.50M 380.10M 380.30M 379.90M 380.30M 382.30M 382.20M 383.70M 385.60M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 378.75M 372.98M 372.88M 374.64M 372.66M 374.58M 376.20M 377.54M 378.83M 380.26M 381.58M
Normalized Net Operating Profit after Tax (NOPAT)		 872 1,544 1,865 1,608 1,776 2,206 1,819 2,259 2,734 3,381 3,999
Normalized NOPAT Margin		 9.02% 15.52% 16.47% 12.92% 13.06% 14.82% 12.68% 13.20% 14.82% 16.50% 17.70%
Pre Tax Income Margin		 11.99% 17.44% 16.96% 16.58% 17.32% 17.21% 13.62% 13.33% 14.54% 17.92% 15.45%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 89.71% 36.21% 34.49% 72.06% 20.18% 37.35% 53.97% 47.64% 44.57% 35.99% 40.73%
Augmented Payout Ratio		 109.13% 84.85% 35.28% 94.61% 28.62% 52.09% 53.97% 47.64% 44.57% 35.99% 40.73%

Quarterly Metrics And Ratios for Stryker

This table displays calculated financial ratios and metrics derived from Stryker's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 10.66% 11.77% 11.20% 9.60% 11.78% 9.73% 8.53% 11.92% 10.68% 11.88% 11.07%
EBITDA Growth		 1.91% 49.04% 19.01% 6.10% 45.56% 26.39% 8.46% 15.92% -46.34% -12.43% 4.46%
EBIT Growth		 0.53% 75.91% 24.86% 6.50% 61.10% 35.94% 11.01% 20.02% -56.93% -17.23% 1.80%
NOPAT Growth		 -15.92% 71.32% 12.63% -8.25% 94.60% 29.49% 9.67% 17.02% -48.73% -13.66% 11.46%
Net Income Growth		 -14.95% 83.28% 12.50% -15.20% 103.02% 33.11% 11.79% 20.52% -52.23% -17.01% 7.15%
EPS Growth		 -15.03% 83.33% 12.21% -15.89% 102.72% 33.12% 10.88% 20.00% -52.68% -17.56% 7.01%
Operating Cash Flow Growth		 0.30% 119.21% 30.06% 18.11% 52.34% -54.16% -7.99% 40.38% 26.37% 22.55% 75.51%
Free Cash Flow Firm Growth		 -797.09% 101.16% 95.66% 92.20% 112.52% -1,883.69% -166.92% -572.05% -275.17% -700.19% -1,139.34%
Invested Capital Growth		 13.90% 2.17% 3.27% 3.42% 2.92% 5.09% 4.18% 7.98% 4.23% 19.00% 17.46%
Revenue Q/Q Growth		 16.14% -8.15% 4.56% -1.74% 18.46% -9.84% 3.41% 1.33% 17.15% -8.86% 2.66%
EBITDA Q/Q Growth		 -4.88% -7.69% 23.72% -2.33% 30.50% -19.85% 6.17% 4.38% -39.59% 30.81% 26.64%
EBIT Q/Q Growth		 -6.74% -10.78% 32.40% -3.34% 41.08% -24.71% 8.13% 4.51% -49.38% 44.70% 32.98%
NOPAT Q/Q Growth		 -25.47% 6.41% 23.62% -6.41% 58.07% -29.19% 4.70% -0.14% -30.75% 19.25% 35.16%
Net Income Q/Q Growth		 -31.00% 5.15% 24.66% -6.23% 65.17% -31.06% 4.70% 1.09% -34.53% 19.78% 35.17%
EPS Q/Q Growth		 -31.31% 4.76% 25.32% -6.74% 65.56% -31.21% 4.39% 0.93% -34.72% 19.86% 35.50%
Operating Cash Flow Q/Q Growth		 12.82% -55.63% 54.61% 52.62% 45.52% -86.65% 210.29% 132.86% 31.00% -87.05% 344.40%
Free Cash Flow Firm Q/Q Growth		 -2.39% 101.24% -475.65% -64.06% 264.42% -276.02% 43.79% -313.08% 57.14% -704.04% 12.93%
Invested Capital Q/Q Growth		 0.11% 1.66% 2.21% -0.58% -0.36% 3.80% 1.33% 3.04% -3.83% 18.51% 0.02%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 62.21% 63.12% 63.67% 64.33% 63.68% 63.57% 63.00% 64.02% 64.85% 63.83% 63.78%
EBITDA Margin		 19.49% 19.59% 23.18% 23.04% 25.38% 22.56% 23.16% 23.86% 12.31% 17.66% 21.79%
Operating Margin		 15.65% 15.38% 19.32% 18.97% 21.62% 18.54% 19.38% 19.75% 9.03% 14.27% 18.48%
EBIT Margin		 14.63% 14.21% 17.99% 17.70% 21.08% 17.60% 18.41% 18.98% 8.20% 13.02% 16.87%
Profit (Net Income) Margin		 10.82% 12.39% 14.77% 14.10% 19.66% 15.03% 15.22% 15.18% 8.48% 11.15% 14.68%
Tax Burden Percent		 73.98% 87.19% 82.09% 79.63% 93.23% 85.37% 82.67% 79.96% 103.41% 85.60% 87.01%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 26.02% 12.81% 17.91% 20.37% 6.77% 14.63% 17.33% 20.04% -3.41% 14.40% 12.99%
Return on Invested Capital (ROIC)		 8.12% 9.02% 10.77% 10.55% 14.53% 11.36% 11.53% 11.53% 7.16% 8.65% 11.61%
ROIC Less NNEP Spread (ROIC-NNEP)		 7.75% 8.62% 10.32% 10.11% 14.26% 10.98% 11.14% 11.23% 6.61% 8.16% 10.94%
Return on Net Nonoperating Assets (RNNOA)		 5.20% 6.59% 7.58% 6.64% 8.77% 6.81% 6.70% 6.53% 3.31% 5.18% 6.68%
Return on Equity (ROE)		 13.31% 15.61% 18.35% 17.19% 23.30% 18.17% 18.23% 18.06% 10.47% 13.83% 18.29%
Cash Return on Invested Capital (CROIC)		 -3.51% 7.65% 6.73% 6.39% 8.90% 7.15% 8.07% 4.75% 6.60% -8.05% -6.51%
Operating Return on Assets (OROA)		 7.55% 7.38% 9.53% 9.51% 11.26% 9.68% 10.29% 10.19% 4.47% 7.08% 9.40%
Return on Assets (ROA)		 5.58% 6.44% 7.83% 7.57% 10.49% 8.27% 8.50% 8.15% 4.63% 6.06% 8.18%
Return on Common Equity (ROCE)		 13.31% 15.61% 18.35% 17.19% 23.30% 18.17% 18.23% 18.06% 10.47% 13.83% 18.29%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 15.55% 15.60% 14.44% 0.00% 17.53% 17.45% 17.82% 0.00% 13.66% 0.00%
Net Operating Profit after Tax (NOPAT)		 602 641 792 741 1,172 830 869 868 601 716 968
NOPAT Margin		 11.58% 13.41% 15.86% 15.10% 20.15% 15.83% 16.02% 15.79% 9.34% 12.21% 16.08%
Net Nonoperating Expense Percent (NNEP)		 0.37% 0.40% 0.45% 0.44% 0.27% 0.37% 0.39% 0.30% 0.56% 0.49% 0.68%
Return On Investment Capital (ROIC_SIMPLE)		 2.03% - - - 3.71% - - - 1.76% 1.90% 2.56%
Cost of Revenue to Revenue		 37.79% 36.88% 36.33% 35.67% 36.32% 36.43% 37.00% 35.98% 35.15% 36.17% 36.22%
SG&A Expenses to Revenue		 32.33% 37.28% 34.21% 34.83% 32.86% 35.09% 34.06% 34.51% 32.66% 39.21% 34.52%
R&D to Revenue		 6.27% 7.10% 6.93% 7.19% 6.02% 7.02% 6.69% 6.86% 5.56% 6.90% 6.76%
Operating Expenses to Revenue		 46.56% 47.74% 44.36% 45.37% 42.06% 45.03% 43.62% 44.27% 55.83% 49.56% 45.30%
Earnings before Interest and Taxes (EBIT)		 761 679 899 869 1,226 923 998 1,043 528 764 1,016
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,014 936 1,158 1,131 1,476 1,183 1,256 1,311 792 1,036 1,312
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.46 6.32 6.60 5.74 6.06 7.07 6.56 6.83 6.65 6.79 7.13
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 357.44 0.00 0.00
Price to Revenue (P/Rev)		 4.92 5.63 5.89 5.17 5.50 6.47 6.06 6.27 6.07 6.12 6.35
Price to Earnings (P/E)		 38.47 40.65 42.32 39.77 35.62 40.36 37.59 38.35 45.86 49.68 51.81
Dividend Yield		 1.18% 1.03% 0.98% 1.11% 1.03% 0.87% 0.93% 0.89% 0.90% 0.88% 0.84%
Earnings Yield		 2.60% 2.46% 2.36% 2.51% 2.81% 2.48% 2.66% 2.61% 2.18% 2.01% 1.93%
Enterprise Value to Invested Capital (EV/IC)		 3.63 4.15 4.33 3.92 4.25 4.88 4.61 4.75 4.87 4.39 4.64
Enterprise Value to Revenue (EV/Rev)		 5.52 6.23 6.48 5.71 5.98 6.97 6.54 6.76 6.48 6.74 6.94
Enterprise Value to EBITDA (EV/EBITDA)		 27.66 29.60 30.21 26.79 26.09 29.53 27.72 28.41 32.22 35.59 37.14
Enterprise Value to EBIT (EV/EBIT)		 37.95 39.68 39.97 35.40 33.40 37.30 34.83 35.43 41.91 46.93 49.33
Enterprise Value to NOPAT (EV/NOPAT)		 40.78 42.75 44.21 40.90 36.61 41.27 38.69 39.70 46.29 51.31 52.50
Enterprise Value to Operating Cash Flow (EV/OCF)		 38.80 41.20 41.69 35.64 33.05 42.10 40.96 38.67 34.50 36.48 34.69
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 54.77 65.37 62.39 48.46 69.95 58.35 103.83 75.33 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.79 0.77 0.75 0.71 0.70 0.67 0.62 0.77 0.66 0.80 0.78
Long-Term Debt to Equity		 0.71 0.70 0.64 0.58 0.59 0.56 0.51 0.66 0.59 0.69 0.70
Financial Leverage		 0.67 0.76 0.73 0.66 0.61 0.62 0.60 0.58 0.50 0.63 0.61
Leverage Ratio		 2.27 2.28 2.22 2.15 2.18 2.11 2.06 2.15 2.11 2.13 2.09
Compound Leverage Factor		 2.27 2.28 2.22 2.15 2.18 2.11 2.06 2.15 2.11 2.13 2.09
Debt to Total Capital		 43.99% 43.60% 42.72% 41.48% 41.14% 40.16% 38.21% 43.45% 39.72% 44.50% 43.90%
Short-Term Debt to Total Capital		 4.02% 4.02% 5.93% 7.54% 6.63% 6.42% 6.55% 6.06% 4.12% 6.36% 4.64%
Long-Term Debt to Total Capital		 39.97% 39.58% 36.79% 33.93% 34.51% 33.73% 31.66% 37.40% 35.61% 38.14% 39.26%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 56.01% 56.40% 57.28% 58.52% 58.86% 59.84% 61.79% 56.55% 60.28% 55.50% 56.10%
Debt to EBITDA		 3.54 3.27 3.10 2.99 2.76 2.60 2.42 2.96 2.99 3.82 3.73
Net Debt to EBITDA		 3.02 2.83 2.75 2.54 2.11 2.11 2.03 2.07 2.00 3.27 3.17
Long-Term Debt to EBITDA		 3.22 2.97 2.67 2.45 2.32 2.18 2.01 2.55 2.68 3.27 3.33
Debt to NOPAT		 5.23 4.73 4.54 4.57 3.88 3.63 3.38 4.14 4.30 5.50 5.27
Net Debt to NOPAT		 4.45 4.09 4.02 3.87 2.97 2.95 2.84 2.89 2.88 4.71 4.48
Long-Term Debt to NOPAT		 4.75 4.29 3.91 3.74 3.25 3.05 2.80 3.56 3.85 4.72 4.71
Altman Z-Score		 3.94 4.50 4.73 4.36 4.51 5.40 5.43 4.84 5.06 4.67 4.93
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.63 1.73 1.54 1.48 1.58 1.71 1.68 1.91 1.95 1.64 1.78
Quick Ratio		 0.87 0.85 0.72 0.70 0.86 0.85 0.81 1.10 1.11 0.80 0.88
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -2,818 35 -131 -215 353 -621 -349 -1,442 -618 -4,971 -4,328
Operating Cash Flow to CapEx		 533.51% 342.31% 452.63% 709.46% 1,053.79% 122.16% 416.45% 867.06% 725.94% 203.25% 607.10%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.52 0.52 0.53 0.54 0.53 0.55 0.56 0.54 0.55 0.54 0.56
Accounts Receivable Turnover		 5.60 6.11 6.07 6.23 5.59 6.27 6.22 6.27 5.83 6.25 6.32
Inventory Turnover		 1.88 1.81 1.74 1.66 1.68 1.62 1.61 1.57 1.70 1.65 1.65
Fixed Asset Turnover		 6.36 6.50 6.61 6.74 6.63 6.66 6.68 6.73 6.78 6.83 6.79
Accounts Payable Turnover		 5.41 5.79 5.82 5.81 5.08 5.81 5.92 6.08 5.10 6.17 6.22
Days Sales Outstanding (DSO)		 65.16 59.76 60.09 58.55 65.26 58.22 58.73 58.24 62.61 58.43 57.77
Days Inventory Outstanding (DIO)		 194.13 202.21 210.28 219.33 216.79 225.09 226.09 231.97 215.22 220.98 220.76
Days Payable Outstanding (DPO)		 67.52 63.05 62.67 62.78 71.87 62.82 61.70 60.03 71.52 59.11 58.67
Cash Conversion Cycle (CCC)		 191.78 198.93 207.71 215.10 210.18 220.50 223.12 230.18 206.31 220.30 219.87
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 28,020 28,484 29,114 28,944 28,839 29,935 30,332 31,254 30,058 35,622 35,628
Invested Capital Turnover		 0.70 0.67 0.68 0.70 0.72 0.72 0.72 0.73 0.77 0.71 0.72
Increase / (Decrease) in Invested Capital		 3,420 606 923 956 819 1,451 1,218 2,310 1,219 5,687 5,296
Enterprise Value (EV)		 101,822 118,091 126,116 113,551 122,665 146,092 139,883 148,467 146,361 156,415 165,312
Market Capitalization		 90,702 106,787 114,647 102,797 112,723 135,634 129,618 137,667 137,257 142,043 151,196
Book Value per Share		 $43.91 $44.60 $45.73 $47.15 $48.94 $50.40 $51.88 $52.87 $54.13 $54.85 $55.45
Tangible Book Value per Share		 ($8.32) ($7.21) ($7.19) ($5.17) ($3.27) ($1.81) ($0.02) ($3.11) $1.01 ($11.25) ($10.35)
Total Capital		 29,664 29,956 30,308 30,595 31,588 32,037 31,984 35,633 34,231 37,711 37,771
Total Debt		 13,048 13,061 12,947 12,690 12,995 12,865 12,222 15,484 13,597 16,781 16,580
Total Long-Term Debt		 11,857 11,857 11,149 10,382 10,901 10,807 10,127 13,325 12,188 14,383 14,829
Net Debt		 11,120 11,304 11,469 10,754 9,942 10,458 10,265 10,800 9,104 14,372 14,116
Capital Expenditures (CapEx)		 188 130 152 148 145 167 152 170 266 123 183
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 3,235 3,736 3,887 3,959 3,638 4,588 4,857 4,479 4,147 5,082 5,002
Debt-free Net Working Capital (DFNWC)		 5,163 5,493 5,365 5,895 6,691 6,995 6,814 9,163 8,640 7,491 7,466
Net Working Capital (NWC)		 3,972 4,289 3,567 3,587 4,597 4,937 4,719 7,004 7,231 5,093 5,715
Net Nonoperating Expense (NNE)		 39 49 54 49 29 42 44 34 55 62 84
Net Nonoperating Obligations (NNO)		 11,404 11,589 11,753 11,039 10,246 10,763 10,570 11,105 9,424 14,692 14,437
Total Depreciation and Amortization (D&A)		 253 257 259 262 250 260 258 268 264 272 296
Debt-free, Cash-free Net Working Capital to Revenue		 17.53% 19.71% 19.98% 19.91% 17.75% 21.89% 22.71% 20.38% 18.35% 21.89% 21.00%
Debt-free Net Working Capital to Revenue		 27.99% 28.98% 27.58% 29.65% 32.64% 33.37% 31.86% 41.70% 38.24% 32.26% 31.35%
Net Working Capital to Revenue		 21.53% 22.63% 18.33% 18.04% 22.43% 23.55% 22.06% 31.87% 32.00% 21.94% 23.99%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.48 $1.56 $1.95 $1.82 $3.01 $2.07 $2.17 $2.18 $1.44 $1.71 $2.32
Adjusted Weighted Average Basic Shares Outstanding		 378.20M 379M 379.70M 379.80M 379.60M 380.40M 381M 381.10M 381M 381.70M 382.20M
Adjusted Diluted Earnings per Share		 $1.47 $1.54 $1.93 $1.80 $2.98 $2.05 $2.14 $2.16 $1.41 $1.69 $2.29
Adjusted Weighted Average Diluted Shares Outstanding		 382.20M 383.20M 383.90M 384M 383.70M 385.10M 385.40M 385.60M 385.60M 386.40M 386.40M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 378.83M 379.61M 379.78M 379.89M 380.26M 380.95M 381.08M 381.22M 381.58M 382.16M 382.31M
Normalized Net Operating Profit after Tax (NOPAT)		 602 641 792 741 1,172 830 869 868 407 746 1,016
Normalized NOPAT Margin		 11.58% 13.41% 15.86% 15.10% 20.15% 15.83% 16.02% 15.79% 6.32% 12.73% 16.88%
Pre Tax Income Margin		 14.63% 14.21% 17.99% 17.70% 21.08% 17.60% 18.41% 18.98% 8.20% 13.02% 16.87%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 44.57% 40.85% 40.42% 43.21% 35.99% 34.48% 34.19% 33.40% 40.73% 43.20% 42.87%
Augmented Payout Ratio		 44.57% 40.85% 40.42% 43.21% 35.99% 34.48% 34.19% 33.40% 40.73% 43.20% 42.87%

Key Financial Trends

Over the last four years, Stryker Corporation (NYSE: SYK) has demonstrated steady revenue growth and profitability, supported by strong operational cash flows and disciplined capital management. Here are the key insights and trends from their recent financial statements through Q2 2025:

  • Consistent Revenue Growth: Operating revenue increased from approximately $4.78 billion in Q1 2023 to $6.02 billion in Q2 2025, reflecting a solid top-line growth trajectory.
  • Improved Profitability: Net income rose from $592 million in Q1 2023 to $884 million in Q2 2025. Correspondingly, diluted EPS increased from $1.54 to $2.29 per share in the same period, indicating enhanced earnings power and efficiency.
  • Strong Operating Cash Flow Generation: Net cash provided by operating activities grew from $445 million in Q1 2023 to $1.11 billion in Q2 2025, highlighting improved cash flow conversion and operational strength.
  • Controlled Operating Expenses: While total operating expenses rose in nominal terms due to growth investments, the company maintained healthy gross profit margins, with gross profit growing from $3.02 billion in Q1 2023 to $3.84 billion in Q2 2025.
  • Capital Investments and Acquisitions: Stryker consistently invested in property, plant, and equipment, with periodic acquisitions (e.g., $4.75 billion acquisition in Q1 2025), supporting future growth and technological capabilities.
  • Dividends and Shareholder Returns: Dividend payouts per share increased modestly from $0.695 in Q3 2022 to $0.84 in Q2 2025, demonstrating commitment to returning cash to shareholders.
  • Improved Balance Sheet Strength: Total equity rose from $16.8 billion in Q1 2023 to $21.2 billion in Q2 2025, while managing long-term debt with repayments and issuances that reflect a balanced capital structure.
  • Fluctuating Debt Levels: Long-term debt levels increased from about $11.86 billion in Q1 2023 to $14.8 billion in Q2 2025, indicating utilization of leverage to fund acquisitions and expansions, which investors should monitor for sustainability.
  • Inventory and Working Capital Management: Inventories grew from $4.33 billion in Q1 2023 to $5.29 billion in Q2 2025, aligning with revenue growth but requiring ongoing management to avoid excess stockpiles.
  • Rising Operating Expenses in Some Quarters: Certain periods saw increased SG&A expenses (e.g., $2.31 billion in Q1 2025), which despite supporting growth initiatives, could pressure margins if not controlled effectively.
  • Negative Changes in Operating Assets and Liabilities: Significant negative adjustments in operating capital in some quarters, such as -$829 million in Q1 2025 and -$521 million in Q2 2024, indicate working capital pressures or timing mismatches that could impact cash flow.

Summary: Stryker has shown resilient growth with higher revenues and earnings accompanied by strong cash flows, supported by strategic capital investments and a generally healthy balance sheet. While leverage usage and working capital need monitoring, the company’s solid financial footing and commitment to shareholder returns make it an attractive profile for investors seeking stability and growth in the medical devices sector.

08/29/25 05:22 PM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About Stryker's Financials

When does Stryker's financial year end?

According to the most recent income statement we have on file, Stryker's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Stryker's net income changed over the last 10 years?

Stryker's net income appears to be on an upward trend, with a most recent value of $2.99 billion in 2024, rising from $515 million in 2014. The previous period was $3.17 billion in 2023. See where experts think Stryker is headed by visiting Stryker's forecast page.

What is Stryker's operating income?
Stryker's total operating income in 2024 was $3.69 billion, based on the following breakdown:
  • Total Gross Profit: $14.44 billion
  • Total Operating Expenses: $10.75 billion
How has Stryker's revenue changed over the last 10 years?

Over the last 10 years, Stryker's total revenue changed from $9.68 billion in 2014 to $22.60 billion in 2024, a change of 133.5%.

How much debt does Stryker have?

Stryker's total liabilities were at $22.34 billion at the end of 2024, a 4.8% increase from 2023, and a 157.2% increase since 2014.

How much cash does Stryker have?

In the past 10 years, Stryker's cash and equivalents has ranged from $1.80 billion in 2014 to $4.34 billion in 2019, and is currently $3.65 billion as of their latest financial filing in 2024.

How has Stryker's book value per share changed over the last 10 years?

Over the last 10 years, Stryker's book value per share changed from 22.72 in 2014 to 54.13 in 2024, a change of 138.2%.


Related Companies

This page (NYSE:SYK) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsoredtc pixel
Generate up to $5,000/month with 10X less money?
The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...
Investors Alley | Sponsoredtc pixel
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsoredtc pixel